Charco Neurotech, based in Cambridge, has raised $10 million in what is said to be the largest “seed”, or initial, financing round this year in Europe for a health technology device.
Charco Neurotech prepares to relaunch CUE1+ following trial findings and medical device certification. Read article
Read moreResults from a clinical trial of CUE1+, a chest-mounted device, has shown it’s well tolerated by people with…
Read moreA double-blind, placebo-controlled study of 50 people with Parkinson’s, published in Parkinson’s Disease, part of the Nature Portfolio, is the first…
Read more
